PENG vs. Femoral Nerve Block for Pain Control in Hip Surgery

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40+
SponsorBenha University

About this trial

The aim of this study is to compare the efficacy of the ultrasound- guided pericapsular nerve group (PENG) block versus the femoral nerve block (FNB) for postoperative pain control in patients undergoing hip surgeries, specifically evaluating pain scores and quadriceps strength.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Aged 40 years or older.

Presenting for hip surgeries

No contraindications to regional anesthesia.

Time of surgery up to 3 hours

Disqualifiers

Inability to provide first-person consent due to cognitive impairment.

Presence of a language barrier that would preclude reliable reporting of symptoms or understanding study procedures.

More than ASA III. 4

Previous neurological deficit in the lower limbs.

Trial design

Design model

Parallel

Treatments tested in this trial

  • PENG BLOCK

    Procedure/Surgery

    Regional anesthesia technique involving the injection of local anesthetic into the myofascial plane between the psoas muscle and the iliopubic eminence.

  • Femoral nerve block

    Procedure/Surgery

    Regional anesthesia technique involving the injection of local anesthetic deep to facia iliaca and lateral to femoral artery circulating femoral nerve trunk.

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: PENG block groupExperimental treatment 1 intervention
Group B: Femoral nerve block groupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Visual Analog Scale (VAS) Score for Pain at 24 Hours.

A scale from 0 to 10 (0 = no pain, 10 = worst imaginable pain). Patients will be asked to rate their pain level at rest.

Time frame
24 hours postoperatively.

Secondary outcomes

1

Quadriceps Muscle Strength

Assessment of muscle power using the Medical Research Council (MRC) scale (range 0-5).

Time frame
6, 12, and 24 hours post-op.
2

Total Opioid Consumptiont

Total cumulative dose of rescue analgesia required by the patient.

Time frame
First 3 days

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: